Target intelligence / Profile preview

Furanone

Molecular classification
Small molecule, Heterocyclic organic compound, Lactone
01

Overview

Furanone refers to a class of heterocyclic organic compounds characterized by a five-membered ring containing one oxygen atom and a carbonyl group, existing commonly as 2-furanone or 3-furanone isomers. In the fields of pharmacology and biotechnology, furanone is recognized as a significant chemical scaffold or ligand class rather than a therapeutic target like a receptor or enzyme. Naturally occurring furanones, such as those derived from the marine alga Delisea pulchra, are widely studied for their ability to inhibit bacterial quorum sensing by interacting with LuxR-type proteins, which disrupts biofilm formation and virulence without necessarily killing the bacteria. In human medicine, the furanone moiety is a structural component of several important molecules, including ascorbic acid (Vitamin C) and the selective COX-2 inhibitor rofecoxib. While rofecoxib demonstrated potent anti-inflammatory effects by targeting the COX-2 enzyme, it was famously withdrawn from the market due to increased cardiovascular risks associated with the furanone-based class of nonsteroidal anti-inflammatory drugs (NSAIDs). Because the term identifies a molecular structure or scaffold found in drugs and natural products rather than a biological macromolecule, it is technically misclassified as a therapeutic target.

Other names
2(5H)-Furanone3(2H)-FuranoneButenolideLactoneFuraneolFuran-2-one
02

Mechanism of action

Furanones primarily act as ligands or inhibitors rather than biological targets; for example, brominated furanones competitively bind to bacterial LuxR-type receptors to inhibit quorum sensing, while furanone derivatives like rofecoxib inhibit the cyclooxygenase-2 (COX-2) enzyme by binding to its active site.

03

Biological functions

Quorum sensing modulationEnzyme inhibitionPheromone signalingMetabolic intermediate
04

Disease associations

Bacterial infectionInflammationCancer
05

Safety considerations

Cardiovascular toxicity (associated with certain furanone-containing COX-2 inhibitors)Cytotoxicity at high concentrationsInterference with beneficial host microbiota in quorum sensing applications
06

Interacting drugs

Rofecoxib

3 more in the full profile.

Beyond the preview

Go deeper on Furanone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Furanone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call